首页> 外国专利> MONOCLONAL ANTIBODY AGAINST PBP2A DERIVED FROM MRSA WITH DUAL BINDING ACTIVITIES

MONOCLONAL ANTIBODY AGAINST PBP2A DERIVED FROM MRSA WITH DUAL BINDING ACTIVITIES

机译:具有双重结合活性的MRSA衍生的抗PBP2A单克隆抗体

摘要

Mouse monoclonal antibodies specifically recognizing the Penicillin Binding Protein 2a (PBP2a) derived from a strain of Methicillin-Resistant Staphylococcus aureus (MRSA) were produced and characterized. The immunogen used to generate an immune response in a mouse was a PBP2a recombinant protein derived from a strain of Methicillin-Resistant Staphylococcus aureus (MRSA). The data showed that both monoclonal antibodies of the disclosure were able to distinguish MRSA from MSSA bacteria. The monoclonal antibodies have distinct recognition patterns for the regions of the PBP2a protein sequence. Epitope mapping has localized regions of the PBP2a protein specifically recognized by one or both of the monoclonal antibodies. The monoclonal antibodies of the present disclosure having the ability to distinguish between MRSA and MSSA strains can be useful as the basis for a diagnostic assay useful in the clinical setting for determining whether and which antibiotics to administer to a patient.
机译:产生并鉴定了特异性识别源自耐甲氧西林金黄色葡萄球菌(MRSA)菌株的青霉素结合蛋白2a(PBP2a)的小鼠单克隆抗体。用于在小鼠中产生免疫应答的免疫原是来自耐甲氧西林金黄色葡萄球菌(MRSA)菌株的PBP2a重组蛋白。数据表明,本发明的两种单克隆抗体都能够将MRSA与MSSA细菌区分开。单克隆抗体对PBP2a蛋白序列的区域具有独特的识别模式。表位作图具有一种或两种单克隆抗体特异性识别的PBP2a蛋白的局部区域。具有区分MRSA和MSSA菌株的能力的本公开的单克隆抗体可以用作诊断测定的基础,该诊断测定在临床环境中用于确定是否和对患者施用哪种抗生素有用。

著录项

  • 公开/公告号US2013022997A1

    专利类型

  • 公开/公告日2013-01-24

    原文格式PDF

  • 申请/专利权人 RUO-PAN HUANG;YING ZHANG;

    申请/专利号US201213555290

  • 发明设计人 YING ZHANG;RUO-PAN HUANG;

    申请日2012-07-23

  • 分类号C07K16/12;C07K14/31;G01N33/577;

  • 国家 US

  • 入库时间 2022-08-21 16:47:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号